BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11231645)

  • 41. Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions: a meta-analysis of randomized, controlled trials.
    de Queiroz Fernandes Araújo JO; Veloso HH; Braga De Paiva JM; Filho MW; Vincenzo De Paola AA
    Am Heart J; 2004 Dec; 148(6):937-43. PubMed ID: 15632875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation.
    Antoniucci D; Valenti R; Migliorini A; Moschi G; Trapani M; Dovellini EV; Bolognese L; Santoro GM
    Am J Cardiol; 2002 Aug; 90(4):353-7. PubMed ID: 12161221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial).
    Nikolsky E; Grines CL; Cox DA; Garcia E; Tcheng JE; Sadeghi M; Mehran R; Lansky AJ; Na Y; Stone GW
    Am J Cardiol; 2007 Apr; 99(8):1055-61. PubMed ID: 17437727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary angioplasty for acute myocardial infarction complicated by cardiogenic shock on admission.
    Rodrigues A; Araújo D; Silva PF; Braga P; Gonçalves M; Simões L; Gama V
    Rev Port Cardiol; 2000 Mar; 19(3):291-7. PubMed ID: 10804775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time.
    Juliard JM; Feldman LJ; Golmard JL; Himbert D; Benamer H; Haghighat T; Karila-Cohen D; Aubry P; Vahanian A; Steg PG
    Am J Cardiol; 2003 Jun; 91(12):1401-5. PubMed ID: 12804723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct percutaneous transluminal coronary angioplasty in acute myocardial infarction. Predictors of short-term outcome and the impact of coronary stenting. Study Group of The Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK).
    Vogt A; Niederer W; Pfafferott C; Engel HJ; Heinrich W; Merx W; Jehle J; Neuhaus KL
    Eur Heart J; 1998 Jun; 19(6):917-21. PubMed ID: 9651716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early abciximab administration in acute myocardial infarction treated with primary coronary intervention.
    Bellandi F; Maioli M; Leoncini M; Toso A; Dabizzi RP
    Int J Cardiol; 2006 Mar; 108(1):36-42. PubMed ID: 15927285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Usefulness of primary angioplasty in nonagenarians with acute myocardial infarction.
    Danzi GB; Centola M; Pomidossi GA; Consonni D; De Matteis S; Stabile A; Sesana M; Anzuini A; Sganzerla P; Cortese B; Migliorini A; Antoniucci D
    Am J Cardiol; 2010 Sep; 106(6):770-3. PubMed ID: 20816115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Half-dose thrombolysis to begin with, when immediate coronary angioplasty in acute myocardial infarction is not possible.
    La Scala E; Steffenino G; Dellavalle A; Baralis G; Meinardi F; Margaria F; Goletto S; Rolfo F
    Ital Heart J; 2004 Sep; 5(9):678-83. PubMed ID: 15568596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elective coronary stent implantation in cardiogenic shock complicating acute myocardial infarction: in-hospital and six-month clinical and angiographic results.
    Fabbiocchi F; Bartorelli AL; Montorsi P; Cozzi S; Trabattoni D; Calligaris G; Loaldi A
    Catheter Cardiovasc Interv; 2000 Aug; 50(4):384-9. PubMed ID: 10931605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Primary PTCA in the treatment of acute myocardial infarct. Experience at the Faculty Hospital in Hradec Kralove].
    Cervinka P; St'ásek J; Cernohorský D; Brtko M; Rozsíval V; Herman A; Varvarovský I; Pleskot M; Dominik J; Malý J
    Vnitr Lek; 2001 Nov; 47(11):757-62. PubMed ID: 11795181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock.
    Tarantini G; Ramondo A; Napodano M; Bilato C; Isabella G; Razzolini R; Iliceto S
    Am J Cardiol; 2004 May; 93(9):1081-5. PubMed ID: 15110196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    Tcheng JE; Kandzari DE; Grines CL; Cox DA; Effron MB; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Fahy M; Lansky AJ; Mehran R; Stone GW;
    Circulation; 2003 Sep; 108(11):1316-23. PubMed ID: 12939213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and efficacy of rescue angioplasty for ST-elevation myocardial infarction with high utilization rates of glycoprotein IIb/IIIa inhibitors.
    Shugman IM; Hsieh V; Cheng S; Parikh D; Tobing D; Wouters N; van der Vijver R; Lo Q; Rajaratnam R; Hopkins AP; Lo S; Leung D; Juergens CP; French JK
    Am Heart J; 2012 Apr; 163(4):649-56.e1. PubMed ID: 22520531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination of abciximab with primary stenting in patients with acute myocardial infarction: a community hospital experience.
    Arjomand H; Mascarenhas DA
    J Invasive Cardiol; 2000 Mar; 12(3):125-9. PubMed ID: 10731278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary angioplasty of unprotected left main coronary artery for acute anterolateral myocardial infarction.
    Sakai K; Nakagawa Y; Kimura T; Ando K; Yokoi H; Iwabuchi M; Inoue K; Nosaka H; Nobuyoshi M
    J Invasive Cardiol; 2004 Nov; 16(11):621-5. PubMed ID: 15550729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction.
    Cura FA; L'Allier PL; Kapadia SR; Houghtaling PL; Dipaola LM; Ellis SG; Topol EJ; Brener SJ;
    Am J Cardiol; 2001 Jul; 88(2):124-8. PubMed ID: 11448407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
    Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ;
    Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Elective primary angioplasty in cardiogenic shock: results from a single center].
    Hernández Hernández F; Hernández Simón P; Andreu Dussac J; Albarrán González-Trevilla A; Velázquez Martín MT; Alonso Gutiérrez M; Tascón Pérez JC
    Rev Esp Cardiol; 2001 Sep; 54(9):1048-54. PubMed ID: 11535190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Results of treating myocardial infarction patients with ST segment elevation in Górnoślaskim Ośrodku Kardiologii in Katowice].
    Maślankiewicz K; Jaklik A; Jakubowski D; Kośmider J; Ochała A; Skowerski M; Wita K; Weglarz P; Zaorski K; Buszman P; Drzewiecki J; Gasior Z; Gross M; Trusz-Gluza M; Tendera M
    Kardiol Pol; 2003 Jun; 58 Suppl 4():IV19-24. PubMed ID: 20527114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.